[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626425":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":27,"centralContacts":32,"locations":38,"responsibleParty":82,"collaborators":84,"id":94,"slug":10,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":95,"sex":101,"minAge":102,"maxAge":10,"enrollmentInfo":103,"targetDuration":10,"studyType":106,"phases":10,"briefSummary":107,"conditions":108,"keywords":111,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Istituto Nazionale di Ricovero e Cura per Anziani","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients hospitalized for acute neurological disorders",null,"Inpatients with one of the following diagnosis: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis\u002Fmeningitis",[13],"Other: collection of blood samples",{"label":15,"type":10,"description":16,"interventionNames":17},"Patients hospitalized for non-neurological diseases with dementia","Inpatients with diagnosis of major neurocognitive disorder according to DSM-5 criteria (2013)",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Patients hospitalized for non-neurological diseases without dementia","Inpatients with non-neurological diseases without dementia",[13],[23],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"collection of blood samples","Serum and EDTA-plasma samples will be collected at baseline",[9,15,19],[28],{"name":29,"affiliation":30,"role":31},"Fabiola Olivieri, Professor","IRCCS INRCA, Ancona, Italy","STUDY_CHAIR",[33],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Anna Rita Bonfigli","CONTACT","+390718003719","a.bonfigli@inrca.it",[39,58,70],{"facility":40,"status":41,"city":42,"state":10,"zip":10,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"IRCCS INRCA Hospital","RECRUITING","Ancona","Italy",{"type":45,"coordinates":46},"Point",[47,48],13.5103,43.60717,{"lat":48,"lon":47},[51,54,56],{"name":52,"role":53,"phone":10,"phoneExt":10,"email":10},"Antonio Cherubini, MD","PRINCIPAL_INVESTIGATOR",{"name":55,"role":53,"phone":10,"phoneExt":10,"email":10},"Riccardo Sarzani, MD",{"name":57,"role":53,"phone":10,"phoneExt":10,"email":10},"Leonardo Biscetti, MD",{"facility":40,"status":41,"city":59,"state":10,"zip":10,"country":43,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Fermo",{"type":45,"coordinates":61},[62,63],13.72274,43.16296,{"lat":63,"lon":62},[66,68],{"name":67,"role":35,"phone":10,"phoneExt":10,"email":10},"Cinzia Giuli, PhD",{"name":69,"role":53,"phone":10,"phoneExt":10,"email":10},"Roberto Brunelli, MD",{"facility":71,"status":41,"city":72,"state":10,"zip":10,"country":43,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Policlinico Universitario","Messina",{"type":45,"coordinates":74},[75,76],15.55256,38.19394,{"lat":76,"lon":75},[79,81],{"name":80,"role":35,"phone":10,"phoneExt":10,"email":10},"Paolino La Spina, MD",{"name":80,"role":53,"phone":10,"phoneExt":10,"email":10},{"type":83,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[85,88,90,92],{"name":86,"class":87},"Ministry of Health, Italy","OTHER_GOV",{"name":89,"class":6},"University of Salento",{"name":91,"class":6},"IRCCS Multimedica",{"name":93,"class":6},"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","100626425",false,"NCT07435467","Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive\u002FFunctional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)","Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive\u002FFunctional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study","BAD-GER","GROUP 1: Patients hospitalized for acute neurological disorders\n\nInclusion criteria:\n\n* Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis\u002Fmeningitis\n\nExclusion criteria:\n\n* no informed consent\n\nGROUP 2: Patients hospitalized for non-neurological diseases with dementia\n\nInclusion criteria:\n\n* inpatients with diagnosis of major neurocognitive disorder according to DSM-5 criteria (2013)\n\nExclusion criteria:\n\n* Inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis\u002Fmeningitis\n* no informed consent\n\nGROUP 3: Patients hospitalized for non-neurological diseases without dementia\n\nInclusion criteria:\n\n* inpatients with non-neurological diseases\n\nExclusion criteria:\n\n* inpatients with one of the following diagnoses: ischemic or hemorrhagic stroke, delirium, status epilepticus, encephalitis\u002Fmeningitis\n* diagnosis of dementia\n* no informed consent","ALL","65 Years",{"count":104,"type":105},400,"ESTIMATED","OBSERVATIONAL","The BAD-GER study is a multicenter, prospective, three-arm observational study serving to validate a prognostic biomarker algorithm for mortality and hospital readmission; this algorithm will be developed through the retrospective analysis of Alzheimer's Disease and neurodegeneration biomarkers in an already available discovery cohort of 700 previously hospitalized geriatric patients.",[109,110],"Alzheimer Disease","Old Age; Dementia",[112,113,114,115,116,117],"aging","geriatric","biomarkers","inflammation","neurodegeneration","mortality","2026-02-24",{"date":120,"type":121},"2026-02-27","ACTUAL",{"date":123,"type":121},"2025-04-09",{"date":125,"type":105},"2026-06-30",{"name":5,"class":6},3]